← Back to directory

Per Karlsson

Researcher Next ID · RN-034535

Researcher · Biochemistry, Genetics and Molecular Biology

Sahlgrenska University Hospital

Gothenburg, Sweden

Accepting doctoral researchersFunding unknown
Works count
550
Citation count
18,972
H-index
62
i10-index
204

Research interests

Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Medicine
Breast Cancer Treatment Studies
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
BRCA gene mutations in cancer
Cancer Genomics and Diagnostics

Publications

  • Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens

    Scientific Reports · 2020 · https://doi.org/10.1038/s41598-020-62848-5

  • Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

    The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(18)30812-x

  • Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

    The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30380-2

  • Mindfulness and its efficacy for psychological and biological responses in women with breast cancer

    Cancer Medicine · 2017 · https://doi.org/10.1002/cam4.1052

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx308

  • Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial

    Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.64.8675

  • Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

    Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.62.3504

  • Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial

    Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2014.56.2595

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt303

  • Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome

    BMC Cancer · 2013 · https://doi.org/10.1186/1471-2407-13-1

  • Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

    PLoS Biology · 2011 · https://doi.org/10.1371/journal.pbio.1001199

  • Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study

    Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.30.8213

  • Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resection for Ductal Carcinoma In Situ of the Breast

    Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.12.7969

  • Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET

    NeuroImage · 2007 · https://doi.org/10.1016/j.neuroimage.2007.10.016

  • DC bus voltage control for a distributed power system

    IEEE Transactions on Power Electronics · 2003 · https://doi.org/10.1109/tpel.2003.818872

  • PET Study of D1 Dopamine Receptor Binding in Neuroleptic-Naive Patients With Schizophrenia

    American Journal of Psychiatry · 2002 · https://doi.org/10.1176/appi.ajp.159.5.761

  • Intracranial Tumors after Exposure to Ionizing Radiation during Infancy: A Pooled Analysis of Two Swedish Cohorts of 28,008 Infants with Skin Hemangioma

    Radiation Research · 1998 · https://doi.org/10.2307/3579984

  • Soft tissue sarcoma after treatment for breast cancer—A Swedish population-based study

    European Journal of Cancer · 1998 · https://doi.org/10.1016/s0959-8049(98)00319-0

  • A PET-study of [ 11 C]FLB 457 binding to extrastriatal D 2 -dopamine receptors in healthy subjects and antipsychotic drug-treated patients

    Psychopharmacology · 1997 · https://doi.org/10.1007/s002130050420

  • Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients

    Psychopharmacology · 1995 · https://doi.org/10.1007/bf02246068

  • Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors.

    PubMed · 1995

  • D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

    American Journal of Psychiatry · 1995 · https://doi.org/10.1176/ajp.152.10.1444

  • Pet study of [11C] β‐CIT binding to monoamine transporters in the monkey and human brain

    Synapse · 1994 · https://doi.org/10.1002/syn.890160203

  • PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor

    Psychopharmacology · 1993 · https://doi.org/10.1007/bf02245691

  • The predictive validity of body mass index based on self-reported weight and height.

    PubMed · 1989

Current projects

    No projects listed.